The declining use of reboxetine in years 2000 to 2006: a pharmacoepidemiological comparative study

J Clin Psychopharmacol. 2012 Apr;32(2):303-5. doi: 10.1097/JCP.0b013e31824a076f.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antidepressive Agents / adverse effects
  • Antidepressive Agents / therapeutic use*
  • Depression / drug therapy*
  • Fluoxetine / adverse effects
  • Fluoxetine / therapeutic use
  • Humans
  • Morpholines / adverse effects
  • Morpholines / therapeutic use*
  • Paroxetine / adverse effects
  • Paroxetine / therapeutic use
  • Pharmacoepidemiology / methods
  • Practice Patterns, Physicians' / trends*
  • Publication Bias
  • Reboxetine
  • Selective Serotonin Reuptake Inhibitors / adverse effects
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*

Substances

  • Antidepressive Agents
  • Morpholines
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Paroxetine
  • Reboxetine